Dashboard
1
Poor Management Efficiency with a low ROCE of 5.73%
- The company has been able to generate a Return on Capital Employed (avg) of 5.73% signifying low profitability per unit of total capital (equity and debt)
2
The company has declared Negative results for the last 4 consecutive quarters
3
Risky - Negative EBITDA
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Other Agricultural Products
CAD 47 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.39
-32.66%
0.48
Revenue and Profits:
Net Sales:
19 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
54.84%
0%
54.84%
6 Months
29.73%
0%
29.73%
1 Year
-4.0%
0%
-4.0%
2 Years
-7.69%
0%
-7.69%
3 Years
-45.45%
0%
-45.45%
4 Years
-71.76%
0%
-71.76%
5 Years
-42.86%
0%
-42.86%
Vext Science, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.05%
EBIT Growth (5y)
-273.39%
EBIT to Interest (avg)
0.92
Debt to EBITDA (avg)
11.63
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
0.32
Tax Ratio
10.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
6.56%
ROE (avg)
5.44%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.64
EV to EBIT
-5.98
EV to EBITDA
19.97
EV to Capital Employed
0.74
EV to Sales
1.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-12.40%
ROE (Latest)
-32.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
18.60
16.60
12.05%
Operating Profit (PBDIT) excl Other Income
3.70
1.30
184.62%
Interest
1.50
1.30
15.38%
Exceptional Items
2.40
1.40
71.43%
Consolidate Net Profit
-2.00
-4.80
58.33%
Operating Profit Margin (Excl OI)
-105.20%
-248.10%
14.29%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 12.05% vs 16.08% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 58.33% vs 62.79% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
49.30
47.00
4.89%
Operating Profit (PBDIT) excl Other Income
-1.60
-2.10
23.81%
Interest
5.90
5.40
9.26%
Exceptional Items
4.00
-1.70
335.29%
Consolidate Net Profit
-30.70
5.90
-620.34%
Operating Profit Margin (Excl OI)
-454.30%
-320.50%
-13.38%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 4.89% vs 1.95% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -620.34% vs -58.45% in Dec 2023
About Vext Science, Inc. 
Vext Science, Inc.
Other Agricultural Products
Vext Science, Inc., formerly Vapen MJ Ventures Corporation, is a Canada-based company, which manufactures cannabis tetrahydrocannabinol (THC) and hemp cannabinoid products. The Company manufactures THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen cannabidiol (CBD) brand.
Company Coordinates 
Company Details
2250 - 1055 West Hastings Street , VANCOUVER BC : V6E 2E9
Registrar Details






